Market Overview

Pluristem to Present at Stem Cell Meeting on the Mesa

Pluristem Therapeutics (NASDAQ: PSTI) announced today that the company will be actively participating in the Stem Cell Meeting on the Mesa on October 14-16, 2013.

William R. Prather RPh, MD, Pluristem's Senior Vice President of Corporate Development will deliver a corporate presentation on Pluristem on October 14th at 5 pm PT. Additionally, Dr. Prather will be presenting a scientific poster on October 16th titled, "PLacental eXpanded (PLX) Cell Treatment Ameliorates Toll-like Receptor-Mediated Preeclampsia in Mice".

The 2013 Stem Cell Meeting on the Mesa is a three-day conference aimed at bringing together senior members of the regenerative medicine industry with the scientific research community to advance stem cell science into cures. The meeting features a nationally recognized Scientific Symposium, attended by leading scientists and researchers, in conjunction with the industry's premier annual Regen Med Partnering Forum. Combined, these meetings attract over 800 attendees from around the globe, fostering key partnerships through one-on-one meetings while also highlighting clinical and commercial progress in the field.

About Pluristem Therapeutics

Pluristem Therapeutics Inc. is a leading developer of placenta-based cell therapies. The Company's patented PLX (PLacental eXpanded) cells are a drug delivery

See full press release

Posted-In: Earnings News Guidance Management M&A Global

 

Most Popular

Related Articles (PSTI)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters